Gene · 9589
Papers3,474
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,474
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular mechanisms involved in Plasmodium gametocytogenesis. | Front Microbiol | 2026 | 41716278 | PubTator, text mining | PubMed |
| m6A demethylase-driven reprogramming of leukemia-associated macrophages predicts improved outcomes in acute myeloid leukemia. | Front Immunol | 2026 | 41710900 | PubTator, text mining | PubMed |
| Curculigoside Induces Ferroptosis in Non-Small Cell Lung Cancer Cells Through a Mechanism Involving Wilms' Tumor 1-Associating Protein-Mediated m6A Modification of GTP Cyclohydrolase 1. | Chem Biol Drug Des | 2026 | 41697851 | PubTator, text mining | PubMed |
| Lipid metabolism in homeostasis and disease. | Signal Transduct Target Ther | 2026 | 41692800 | PubTator, text mining | PubMed |
| The mechanistic role of Wilms tumor 1-associated protein in cancer pathogenesis, immunity, immunotherapy, and therapy resistance. | Invest New Drugs | 2026 | 41649756 | PubTator, text mining | PubMed |
| WTAP Contributes to Periodontitis Pathogenesis by Promoting PDLSC Senescence and Impairing Osteogenic Differentiation via m6A-Dependent Regulation of TP53BP1. | Immun Inflamm Dis | 2026 | 41641517 | PubTator, text mining | PubMed |
| N6-methyladenosine RNA methylation regulators and their target SOX2 as circulating biomarkers of colorectal cancer: Insights towards early diagnosis and staging. | Comput Biol Med | 2026 | 41621400 | PubTator, text mining | PubMed |
| The role of m6A RNA methyltransferase METTL3 in drug resistance mechanisms in acute myeloid leukemia. | Blood Res | 2026 | 41615563 | PubTator, text mining | PubMed |
| The SAM-m6A axis as an unexplored therapeutic hub for plant-derived regulation of disease metabolism. | Pharmacol Res | 2026 | 41611142 | PubTator, text mining | PubMed |
| Single-cell and machine learning approaches reveal METTL14-mediated autophagy via PI3K/AKT signaling in invasive PitNET. | Cancer Cell Int | 2026 | 41588537 | PubTator, text mining | PubMed |
| Identifying a Novel Six-LncRNA Signature Evaluates Survival and Reveals AC129507.1 as the m6A-Target to Regulate Ferroptosis in Gastric Cancer. | J Gastroenterol Hepatol | 2026 | 41575492 | PubTator, text mining | PubMed |
| Meta-unstable mRNAs in activated CD8+ T cells are defined by interlinked AU-rich elements and m6A mRNA methylation. | Nat Commun | 2026 | 41571642 | PubTator, text mining | PubMed |
| Upregulation of m6A writer WTAP by histone lactylation promotes inflammatory response via TLR2 in neutrophils. | Sci China Life Sci | 2026 | 41569386 | PubTator, text mining | PubMed |
| piR-1170 drives brain metastasis and immune evasion via WTAP-mediated m6A methylation reprogramming in triple-negative breast cancer. | Mol Cancer | 2026 | 41566302 | PubTator, text mining | PubMed |
| Time Is of the Essence: Temporal Dynamics of Epigenetic Landscapes as Therapeutic Targets in Traumatic Brain Injury. | ACS Chem Neurosci | 2026 | 41565603 | PubTator, text mining | PubMed |
| Targeting WTAP/ROR1/WNT5A-Mediated Crosstalk Between Glioma Stem Cells and Macrophages to Normalize Tumor Vasculature and Enhance Chemotherapy. | Adv Sci (Weinh) | 2026 | 41562250 | PubTator, text mining | PubMed |
| Development of a split-toxin CRISPR screening platform to systematically identify regulators of human myoblast fusion. | Nat Commun | 2026 | 41540035 | PubTator, text mining | PubMed |
| Epigenetic mechanism of LncRNA KCNQ1OT1 in high-glucose-induced podocyte injury via m6A methylation modification. | Exp Cell Res | 2026 | 41539350 | PubTator, text mining | PubMed |
| METTL16 Inhibits Lens Epithelial Cells Function in Diabetic Cataract via m6A-Modified DKK1-Mediated Wnt/β-Catenin Signaling. | Invest Ophthalmol Vis Sci | 2026 | 41533902 | PubTator, text mining | PubMed |
| WTAP Interferes With Ferroptosis by Regulating the m6A Modification of SF3B1 to Mediate the Malignant Progression of Endometrial Cancer. | J Biochem Mol Toxicol | 2026 | 41532731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9589/papers?page=5